Government Information

Earl Gregg Swem Library

Diminishing Funding and Rising Expectations: Trends and Challenges for Public Research Universities

Categories: Education-Higher,Science/Technology

http://www.nsf.gov/nsb/sei/companion2/files/nsb1245.pdf

Subtitled: A Companion to Science and Engineering Indicators 2012.  Highlights the importance of research universities to state and the national economies, rising public expectations for university education and research, and the challenges posed by diminishing state support.  From the National Science Board of the National Science Foundation

 

Crime in the United States: 2011

Categories: Crime/Justice,Headlines,Statistics

 http://www.fbi.gov/about-us/cjis/ucr/crime-in-the-u.s/2011/crime-in-the-u.s.-2011

Annual compilation of crime statistics including violent and property crimes.  Reports a decrease of 3.8% in violent crime from the 2010 totals.  From the Federal Bureau of Investigation

 

Conditions Observed at New England Compounding Center Facility

Categories: Advertising/Marketing,Govt/Business Scandals,Health/Medical

http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm325994.htm

Press release on conditions found at the New England pharmacy facility which caused an outbreak of meningitis.  Includes links to the inspection report, FAQ document, and an update on the fungal meningitis outbreak.  From the Food and Drug Administration

 

Mikoyan’s Mission Impossible in Cuba: New Soviet Evidence on the Cuban Missile Crisis

Categories: Communism,Cuba,History,Russia

http://www.gwu.edu/~nsarchiv/NSAEBB/NSAEBB400/

A collection of documents that provide insights on Soviet thinking during the 1962 Cuban missile crisis.  From the National Security Archive

 

Medicare Part D Coverage Gap: Discount Program Effects and Brand-Name Drug Price Trends

Categories: Elderly,Health/Medical,Laws/Regulations,Medicare/Medicaid

http://www.gao.gov/assets/650/648975.pdf

Examines changes made to the so-called Donut Hole coverage gap for Medicare recipients between initial and catastrophic coverage by the Affordable Care Act and the effect of the changes on drug prices, plan sponsors, drug manufacturers, and pharmacy benefit managers.  From the Government Accountability Office